Ihuman Inc Stock Performance
| IH Stock | USD 1.52 0.03 1.94% |
The company retains a Market Volatility (i.e., Beta) of 1.02, which attests to a somewhat significant risk relative to the market. Ihuman returns are very sensitive to returns on the market. As the market goes up or down, Ihuman is expected to follow. At this point, Ihuman Inc has a negative expected return of -0.038%. Please make sure to check out Ihuman's kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if Ihuman Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Ihuman Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong technical indicators, Ihuman is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders. ...more
Forward Dividend Yield 0.0552 | Payout Ratio 0.4914 | Dividend Date 2024-05-15 | Ex Dividend Date 2024-03-27 |
1 | International companies to host live webcasts at Deutsche Banks Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024 | 09/17/2024 |
2 | iHuman Inc. Announces Second Quarter 2024 Unaudited Financial Results | 09/27/2024 |
3 | Case IH Attend Expo Prado in Uruguay | 10/03/2024 |
4 | IH Stock Surges 5.86 percent Amid Strong Earnings in the Education Service Sector | 10/21/2024 |
5 | A New Era of Smart Harvesting Case IH Launches Axial-Flow 160 Series to the Argentine Market | 11/21/2024 |
| Begin Period Cash Flow | 1 B | |
| Free Cash Flow | 165.6 M |
Ihuman |
Ihuman Relative Risk vs. Return Landscape
If you would invest 164.00 in Ihuman Inc on August 26, 2024 and sell it today you would lose (12.00) from holding Ihuman Inc or give up 7.32% of portfolio value over 90 days. Ihuman Inc is generating negative expected returns and assumes 4.0863% volatility on return distribution over the 90 days horizon. Put differently, 36% of stocks are less risky than Ihuman on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Ihuman Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ihuman's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Ihuman Inc, and traders can use it to determine the average amount a Ihuman's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0093
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IH |
Estimated Market Risk
| 4.09 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ihuman is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ihuman by adding Ihuman to a well-diversified portfolio.
Ihuman Fundamentals Growth
Ihuman Stock prices reflect investors' perceptions of the future prospects and financial health of Ihuman, and Ihuman fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ihuman Stock performance.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0456 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | (76.09 M) | ||||
| Shares Outstanding | 23.57 M | ||||
| Price To Earning | 7.83 X | ||||
| Price To Book | 0.63 X | ||||
| Price To Sales | 0.08 X | ||||
| Revenue | 1.02 B | ||||
| Gross Profit | 660.62 M | ||||
| EBITDA | 171.58 M | ||||
| Net Income | 180.91 M | ||||
| Cash And Equivalents | 1.05 B | ||||
| Cash Per Share | 16.08 X | ||||
| Total Debt | 3.86 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 2.27 X | ||||
| Book Value Per Share | 17.36 X | ||||
| Cash Flow From Operations | 172.12 M | ||||
| Earnings Per Share | (0.16) X | ||||
| Market Capitalization | 79.6 M | ||||
| Total Asset | 1.45 B | ||||
| Retained Earnings | (140.46 M) | ||||
| Working Capital | 891.68 M | ||||
About Ihuman Performance
By evaluating Ihuman's fundamental ratios, stakeholders can gain valuable insights into Ihuman's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ihuman has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ihuman has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 20.31 | 19.29 | |
| Return On Tangible Assets | 0.13 | 0.13 | |
| Return On Capital Employed | 0.17 | 0.16 | |
| Return On Assets | 0.12 | 0.13 | |
| Return On Equity | 0.19 | 0.18 |
Things to note about Ihuman Inc performance evaluation
Checking the ongoing alerts about Ihuman for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ihuman Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ihuman Inc generated a negative expected return over the last 90 days | |
| Ihuman Inc may become a speculative penny stock | |
| Ihuman Inc has high historical volatility and very poor performance | |
| Latest headline from accesswire.com: A New Era of Smart Harvesting Case IH Launches Axial-Flow 160 Series to the Argentine Market |
- Analyzing Ihuman's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ihuman's stock is overvalued or undervalued compared to its peers.
- Examining Ihuman's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ihuman's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ihuman's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ihuman's stock. These opinions can provide insight into Ihuman's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ihuman Stock analysis
When running Ihuman's price analysis, check to measure Ihuman's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ihuman is operating at the current time. Most of Ihuman's value examination focuses on studying past and present price action to predict the probability of Ihuman's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ihuman's price. Additionally, you may evaluate how the addition of Ihuman to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Correlations Find global opportunities by holding instruments from different markets |